ATE187640T1 - Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten - Google Patents

Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten

Info

Publication number
ATE187640T1
ATE187640T1 AT96901859T AT96901859T ATE187640T1 AT E187640 T1 ATE187640 T1 AT E187640T1 AT 96901859 T AT96901859 T AT 96901859T AT 96901859 T AT96901859 T AT 96901859T AT E187640 T1 ATE187640 T1 AT E187640T1
Authority
AT
Austria
Prior art keywords
high molecular
delayed release
tablet form
medicinal product
release based
Prior art date
Application number
AT96901859T
Other languages
English (en)
Inventor
Jean-Pierre Collaueri
Guillaume Conrath
Paul-Joel Derian
Gabriel Gousset
Frederic Mauger
Original Assignee
Rhodia Chimie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie Sa filed Critical Rhodia Chimie Sa
Application granted granted Critical
Publication of ATE187640T1 publication Critical patent/ATE187640T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96901859T 1995-01-27 1996-01-26 Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten ATE187640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500946A FR2729857B1 (fr) 1995-01-27 1995-01-27 Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
PCT/FR1996/000133 WO1996022767A1 (fr) 1995-01-27 1996-01-26 Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire

Publications (1)

Publication Number Publication Date
ATE187640T1 true ATE187640T1 (de) 2000-01-15

Family

ID=9475564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901859T ATE187640T1 (de) 1995-01-27 1996-01-26 Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten

Country Status (10)

Country Link
US (1) US6221393B1 (de)
EP (1) EP0805676B1 (de)
JP (1) JPH10512873A (de)
AT (1) ATE187640T1 (de)
AU (1) AU4627096A (de)
CA (1) CA2210321C (de)
DE (1) DE69605649T2 (de)
ES (1) ES2143180T3 (de)
FR (1) FR2729857B1 (de)
WO (1) WO1996022767A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
FR2785191B1 (fr) * 1998-11-02 2002-05-31 Rhodia Chimie Sa Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
US20030130297A1 (en) * 2001-07-06 2003-07-10 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
EP1404332A1 (de) * 2001-07-06 2004-04-07 Penwest Pharmaceuticals Company Herstellung von verzögert freisetzenden oxymorphon formulierungen
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
CA2498798A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
WO2004087126A1 (en) * 2003-03-31 2004-10-14 Pliva-Lachema A.S. Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
EP1645568A4 (de) 2003-07-11 2007-06-27 Asahi Kasei Chemicals Corp Funktionelles stärkepulver
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
EP1909770B1 (de) * 2005-02-22 2013-03-20 Sun Pharmaceutical Industries Limited Kontrolliert freigesetzte, orale zusammensetzung mit levetiracetam
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
EP2044126B1 (de) * 2006-07-20 2012-11-14 Rhodia, Inc. Verfahren zur herstellung von derivatisiertem guarkernmehl und auf diese weise hergestelltes derivatisiertes guarkernmehl
CA2652981C (en) * 2006-10-10 2012-05-01 Penwest Pharmaceuticals Co. Robust sustained release formulations
US20080085304A1 (en) * 2006-10-10 2008-04-10 Penwest Pharmaceuticals Co. Robust sustained release formulations
US9993433B2 (en) 2010-05-10 2018-06-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
FR3020571B1 (fr) * 2014-05-05 2017-08-25 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Co-granules de gomme de xanthane et de gomme d'acacia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8515484D0 (en) * 1985-06-19 1985-07-24 Shell Int Research Heteropolysaccharide particles
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
FR2600267A1 (fr) * 1986-06-19 1987-12-24 Rhone Poulenc Chimie Granules de biopolymere a dispersabilite et dissolution rapides
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
AU5745394A (en) * 1992-12-30 1994-08-15 Fmc Corporation Readily available konjac glucomannan sustained release excipient
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine

Also Published As

Publication number Publication date
AU4627096A (en) 1996-08-14
ES2143180T3 (es) 2000-05-01
DE69605649D1 (de) 2000-01-20
FR2729857A1 (fr) 1996-08-02
WO1996022767A1 (fr) 1996-08-01
DE69605649T2 (de) 2000-06-21
EP0805676B1 (de) 1999-12-15
FR2729857B1 (fr) 1997-04-04
CA2210321C (fr) 2003-03-18
US6221393B1 (en) 2001-04-24
EP0805676A1 (de) 1997-11-12
CA2210321A1 (fr) 1996-08-01
JPH10512873A (ja) 1998-12-08
MX9705611A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
ATE187640T1 (de) Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten
ES2073677T3 (es) Revestimientos de liberacion sostenida y enmascaramiento del sabor para productos farmaceuticos.
RS49963B (sr) Kompozicija koja obuhvata hranjivi materijal i biljni ekstrat korisna za prevenciju i tretiranje virusa humane imunodeficijencije i drugih infektivnih bolesti
FI973419A (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
DK0525389T3 (da) Fremgangsmåde til fremstilling af mekanisk stabile, let henfaldende tabletter af formlegemer, som indeholder aktivt stof
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
KR960703570A (ko) 부형제와 함께 프로게스테론 및 폴리에틸렌글리콜을 함유하는 경구투여용 신규약제(a novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together wtth an excipient)
DK1167354T3 (da) Racemisk huperzin A
CZ15295A3 (en) Solid pharmaceutical dosing unit
HUP9901021A2 (hu) Famciklovirt nagy koncentrációban tartalmazó gyógyászati tabletták
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제
KR950002772A (ko) 한방변비치료제
RO115597B1 (ro) Comprimate de aspirină tamponată
UA10109A (uk) Дитячий лікарський засіб "валькофен", який має жарознижуючу, анальгетичну та протизапальну активність
UA29946A (uk) Ентеросорбент "фібросорб віта"
UA10108A (uk) Дитячий лікарський засіб "паравіт", який виявляє жарознижуючу та анальгетичну дію

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties